Entecavir resistance in a patient with treatment-naïve HBV: A case report

Among nucleos(t)ide analogue therapies for hepatitis B virus (HBV) treatment, entecavir (ETV) and tenofovir disoproxil fumarate (TDF)/tenofovir alafenamide are associated with the lowest rate of drug resistance. ETV is a drug requiring at least three substitutions in the reverse transcriptase (RT) d...

Descripción completa

Detalles Bibliográficos
Autores principales: Marino, Andrea, Cosentino, Federica, Ceccarelli, Manuela, Moscatt, Vittoria, Pampaloni, Alessio, Scuderi, Daniele, D'Andrea, Flavia, Rullo, Emmanuele Venanzi, Nunnari, Giuseppe, Benanti, Francesco, Celesia, Benedetto Maurizio, Cacopardo, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060856/
https://www.ncbi.nlm.nih.gov/pubmed/33903819
http://dx.doi.org/10.3892/mco.2021.2275

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8060856/
https://www.ncbi.nlm.nih.gov/pubmed/33903819
http://dx.doi.org/10.3892/mco.2021.2275

Ejemplares similares